DEGLUDEK INZULINA in English translation

• insulin degludec

Examples of using Degludek inzulina in Croatian and their translations into English

Ne postoje razlike u farmakokinetici degludek inzulina između zdravih ispitanika
There is no difference in the pharmacokinetics of insulin degludec between healthy subjects

Najveća dnevna doza lijeka Xultophy je 50 odmjernih koraka 50 jedinica degludek inzulina i 1, 8 mg liraglutida.
The maximum daily dose of Xultophy is 50 dose steps 50 units of insulin degludec and 1.8 mg of liraglutide.

Ukupna izloženost degludek inzulinu nakon primjene lijeka Xultophy bila je ekvivalentna onoj nakon primjene samog degludek inzulina, dok je Cmax bio 12% viši.
The overall exposure of insulin degludec was equivalent following administration of Xultophy versus insulin degludec alone while the Cmax was higher by 12.

Uz primjenu lijeka Ryzodeg, ukupna izloženost se proporcionalno povećava povećanjem doze bazalnog sastojka(degludek inzulina) i sastojka koji se primjenjuje uz obrok(aspart inzulin)
Total exposure with Ryzodeg increases proportionally with increasing dose of the basal component(insulin degludec) and the meal-time component(insulin aspart)

preporučena početna doza lijeka Xultophy je 16 odmjernih koraka(16 jedinica degludek inzulina i 0, 6 mg liraglutida)
the recommended starting dose of Xultophy is 16 dose steps(16 units insulin degludec and 0.6 mg liraglutide)

dodavanje lijeka Xultophy u njihovo liječenje uspoređeno je s dodavanjem jedne od djelatnih tvari lijeka, degludek inzulina ili liraglutida.
adding Xultophy to their treatment was compared with adding either of its active substances, insulin degludec or liraglutide.

Xultophy ima stabilan farmakodinamički profil i trajanje djelovanja koje odražava kombinaciju pojedinačnih profila djelovanja degludek inzulina i liraglutida, što omogućuje primjenu lijeka Xultophy jednom dnevno,
Xultophy has a stable pharmacodynamic profile with a duration of action reflecting the combination of the individual action profiles of insulin degludec and liraglutide that allows for administration of Xultophy once daily at any time of the day with

stabilnih multiheksamera degludek inzulina te nastaje depo inzulina u supkutanom tkivu, pri čemu nije ometen brzi
stable multi-hexamers of insulin degludec are formed creating a depot of insulin in the subcutaneous tissue,

Svrha edukacijskih materijala je osvijestiti činjenicu da Xultophy sadrži fiksnu kombinaciju degludek inzulina i liraglutida(lijeka na bazi GLP-1)
The educational materials are aimed at increasing awareness about the fact Xultophy contains a fixed combination of insulin degludec and liraglutide(a GLP1-based product)

Farmakokinetička svojstva degludek inzulina u djece(1-11 godina)
The pharmacokinetic properties of insulin degludec in children(1-11 years)

Tjelesna težina smanjila se za 0, 4 kg, uz procijenjenu razliku u liječenju između lijeka Xultophy i degludek inzulina od-2, 80 kg(p<
Body weight was reduced by 0.4 kg with an estimated treatment difference between Xultophy and insulin degludec of -2.80 kg(p<

stabilnog učinka degludek inzulina na snižavanje razine glukoze s malom varijabilnošću u djelovanju inzulina dan za danom.
circulation leading to a flat and stable glucose-lowering-effect of insulin degludec with a low day-to- day variability in insulin action.

Degludek inzulin i aspart inzulin malo su drugačiji od humanog inzulina..
Insulin degludec and insulin aspart are slightly different from human insulin..

Nije poznato izlučuje li se degludek inzulin ili liraglutid u majčino mlijeko.
It is not known whether insulin degludec or liraglutide is excreted in human milk.

Jakost inzulinskih analoga, uključujući degludek inzulin, izražava se u jedinicama U.
The potency of insulin analogues, including insulin degludec, is expressed in units U.

Tresiba 100 jedinica/ml otopina za injekciju u ulošku degludek inzulin.
Tresiba 100 units/mL solution for injection in cartridge insulin degludec.

Tresiba 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici degludek inzulin.
Tresiba 100 units/mL solution for injection in pre-filled pen insulin degludec.

Xultophy 100 jedinica/ml+ 3, 6 mg/ml otopina za injekciju degludek inzulin+ liraglutid.
Xultophy 100 units/mL+ 3.6 mg/mL solution for injection insulin degludec+ liraglutide.

Ryzodeg je lijek koji sadrži djelatne tvari degludek inzulin i aspart inzulin..
Ryzodeg is a medicine that contains the active substances insulin degludec and insulin aspart.

U skupini koja je uzimala degludek inzulin+ liraglutid,
In the insulin degludec+ liraglutide arm, the insulin dose